Literature DB >> 3601664

Identification of proteins interacting with the enhancer of human U2 small nuclear RNA genes.

L Janson, C Bark, U Pettersson.   

Abstract

Protein/DNA interactions in the human U2 RNA gene enhancer have been characterized by DNase I footprint and DMS methylation protection analyses. Nuclear factors present in both HeLa and B cell extracts have been shown to protect an approximately 70 bp region from DNase I digestion. DMS and DNase I footprint competition studies demonstrated that the entire footprint can be accounted for by interactions with two previously identified transcription factors. One of these recognizes the so called octanucleotide-motif ATGCAAAT (transcription factor IgNF-A) which has been shown to be essential for transcription. The other is the transcription factor Sp1 which binds to three target sequences located adjacent to the octameric motif. The Sp1 interactions appear to be required for full transcriptional activity. No differences in the DNase I footprint patterns or in the DMS methylation protections were observed when nuclear extracts from HeLa cells, two different B cell lines, or from the adenovirus-transformed 293 cell line were compared.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3601664      PMCID: PMC305943          DOI: 10.1093/nar/15.13.4997

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  DNAse footprinting: a simple method for the detection of protein-DNA binding specificity.

Authors:  D J Galas; A Schmitz
Journal:  Nucleic Acids Res       Date:  1978-09       Impact factor: 16.971

2.  Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40.

Authors:  F L Graham; P J Abrahams; C Mulder; H L Heijneker; S O Warnaar; F A De Vries; W Fiers; A J Van Der Eb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.

Authors:  G Klein; B Giovanella; A Westman; J S Stehlin; D Mumford
Journal:  Intervirology       Date:  1975       Impact factor: 1.763

4.  Specific protein binding to the simian virus 40 enhancer in vitro.

Authors:  A G Wildeman; M Zenke; C Schatz; M Wintzerith; T Grundström; H Matthes; K Takahashi; P Chambon
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

5.  A transcription factor which binds to the enhancers of SV40, immunoglobulin heavy chain and U2 snRNA genes.

Authors:  D Bohmann; W Keller; T Dale; H R Schöler; G Tebb; I W Mattaj
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

6.  Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.

Authors:  G Klein; L Dombos; B Gothoskar
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

7.  Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II.

Authors:  W S Dynan; R Tjian
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

8.  Transcription of a gene for human U1 small nuclear RNA.

Authors:  J T Murphy; R R Burgess; J E Dahlberg; E Lund
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

9.  In vivo sequence requirements of the SV40 early promotor region.

Authors:  C Benoist; P Chambon
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

10.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

View more
  28 in total

1.  Modulation of iron on mitochondrial aconitase expression in human prostatic carcinoma cells.

Authors:  Horng-Heng Juang
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

2.  Octamer and SPH motifs in the U1 enhancer cooperate to activate U1 RNA gene expression.

Authors:  K A Roebuck; D P Szeto; K P Green; Q N Fan; W E Stumph
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

3.  Cooperative interactions between transcription factors Sp1 and OTF-1.

Authors:  L Janson; U Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression.

Authors:  A C Ström; M Forsberg; P Lillhager; G Westin
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

5.  Specific binding sites for a pol III transcriptional repressor and pol II transcription factor YY1 within the internucleosomal spacer region in primate Alu repetitive elements.

Authors:  G W Humphrey; E W Englander; B H Howard
Journal:  Gene Expr       Date:  1996

6.  Molecular and functional characterization of the promoter region of the mouse LDH/C gene: enhancer-assisted, Sp1-mediated transcriptional activation.

Authors:  J Yang; K Thomas
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

7.  Cytosine methylation in CTF and Sp1 recognition sites of an HSV tk promoter: effects on transcription in vivo and on factor binding in vitro.

Authors:  J Ben-Hattar; P Beard; J Jiricny
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

8.  Initiation and termination of human U1 RNA transcription requires the concerted action of multiple flanking elements.

Authors:  H E Neuman de Vegvar; J E Dahlberg
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

9.  Two distinct domains in Staf to selectively activate small nuclear RNA-type and mRNA promoters.

Authors:  C Schuster; A Krol; P Carbon
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

10.  Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines.

Authors:  G V Raj; K Khalili
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.